Home>News> Boehringer Ingelheim plans 3-year, $84M expansion in Mexico

Boehringer Ingelheim plans 3-year, $84M expansion in Mexico

Boehringer Ingelheim intends to make a significant investment in its three manufacturing sites in Mexico in the next three years, starting with its site near Mexico City where it makes diabetes meds.   

The drugmaker today said it will invest about 1 billion Mexican pesos ($52 million) over the next two years in its Xochimilco site, a sum that should boost capacity. The goal is to increase production to 2.5 billion tablets annually in 2028 from about 1.6 billion tablets now, the company said, according to a translated story in Milenio. 

Tags: